Page last updated: 2024-10-27

fluorouracil and Carcinoma in Situ

fluorouracil has been researched along with Carcinoma in Situ in 98 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.

Research Excerpts

ExcerptRelevanceReference
"Patients with stage II/III breast cancer received four cycles of XT (capecitabine 1650 mg/m(2) on days 1-14 and docetaxel 60 mg/m(2) on day 8 every 3 weeks), followed by four cycles of FEC (5-fluorouracil 500 mg/m(2), epirubicin 90 mg/m(2), and cyclophosphamide 500 mg/m(2) on day 1 every 3 weeks)."9.14A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer. ( Hayashida, T; Ikeda, T; Jinno, H; Kitagawa, Y; Mukai, M; Sakata, M; Takahashi, M, 2010)
"The clinical and pathologic response of carcinoma in situ of the vulva in a 42-year-old woman treated with topical 5-fluorouracil is reported."8.75Topical 5-fluorouracil in the treatment of carcinoma in situ of the vulva. ( Carson, TE; Hoskins, WJ; Wurzel, JF, 1976)
"The authors previously reported the safety and short-term efficacy of ablative fractional laser (AFXL)-assisted delivery of topical fluorouracil in the treatment of superficial basal cell carcinoma (sBCC) and squamous cell carcinoma in situ (SCCis)."7.83Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study. ( Gan, SD; Hsu, SH; Konnikov, N; Liang, CA; Nguyen, BT, 2016)
"Topical therapeutic options for cutaneous squamous cell carcinoma in situ include 5-fluorouracil cream and imiquimod cream."7.73Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy. ( Mings, SM; Ondo, AL; Pestak, RM; Shanler, SD, 2006)
"To assess safety, tolerance, and disease control of transurethral resection of the bladder tumor (TURB) plus concurrent cisplatin, 5-fluorouracil (5-FU), and radiation therapy (RT) with selective organ preservation in patients with bladder cancer."7.71Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. ( Dunst, J; Grabenbauer, GG; Kühn, R; Papadopoulos, T; Rödel, C; Sauer, R; Schrott, KM; Zörcher, T, 2002)
"Local treatment with 5% of 5-Fluorouracil (5-Fu) in the form of globules was carried out on 37 patients with carcinoma in situ of the uterine cervix, established histologically, as the application was performed once daily for a period of 14-20 days."7.68[The conservative treatment of carcinoma in situ of the cervix uteri by the local application of 5-fluorouracil]. ( Chakalova, G; Karag'ozov, A; Marinova, L; Ralcheva, Ts, 1991)
"Topical 5-fluorouracil (5-FU) has been suggested as a simple and effective approach to the treatment of carcinoma in situ of the vulva."7.66Treatment of carcinoma in situ of the vulva with topical 5-fluorouracil. ( Lifshitz, S; Roberts, JA, 1980)
"A patient with vaginal carcinoma in situ was treated with 5-fluorouracil in a less intensive regimen that previously recorded."7.66A new regimen for the treatment of vaginal carcinoma in situ using 5-fluorouracil. Case report. ( Hawthorne, JH; Stokes, IM; Sworn, MJ, 1980)
"Seven adult men with biopsy-confirmed erythroplasia of Queyrat (EQ) were cured of their disease with topically applied 5-fluorouracil (5-FU) under occlusion."7.65Erythroplasia of Queyrat: treatment with topical 5-fluorouracil. ( Carson, TE; Goette, DK, 1976)
"Anal cancer is an increasing issue in HIV-positive men who have sex with men (MSM)."6.78Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. ( de Vries, HJ; Dijkgraaf, MG; Prins, JM; Richel, O; van Noesel, CJ, 2013)
"The relation between the induction of delayed hypersensitivity reactions to 5-FU following treatment with topical 5-FU and the cure rate for cutaneous neoplasms showed a trend toward correlation."5.25Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers. ( Ichinose, H; Krementz, ET; Litwin, MS; Mansell, PW, 1975)
"Patients with stage II/III breast cancer received four cycles of XT (capecitabine 1650 mg/m(2) on days 1-14 and docetaxel 60 mg/m(2) on day 8 every 3 weeks), followed by four cycles of FEC (5-fluorouracil 500 mg/m(2), epirubicin 90 mg/m(2), and cyclophosphamide 500 mg/m(2) on day 1 every 3 weeks)."5.14A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer. ( Hayashida, T; Ikeda, T; Jinno, H; Kitagawa, Y; Mukai, M; Sakata, M; Takahashi, M, 2010)
"The clinical and pathologic response of carcinoma in situ of the vulva in a 42-year-old woman treated with topical 5-fluorouracil is reported."4.75Topical 5-fluorouracil in the treatment of carcinoma in situ of the vulva. ( Carson, TE; Hoskins, WJ; Wurzel, JF, 1976)
"The authors previously reported the safety and short-term efficacy of ablative fractional laser (AFXL)-assisted delivery of topical fluorouracil in the treatment of superficial basal cell carcinoma (sBCC) and squamous cell carcinoma in situ (SCCis)."3.83Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study. ( Gan, SD; Hsu, SH; Konnikov, N; Liang, CA; Nguyen, BT, 2016)
"Topical therapeutic options for cutaneous squamous cell carcinoma in situ include 5-fluorouracil cream and imiquimod cream."3.73Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy. ( Mings, SM; Ondo, AL; Pestak, RM; Shanler, SD, 2006)
"To assess safety, tolerance, and disease control of transurethral resection of the bladder tumor (TURB) plus concurrent cisplatin, 5-fluorouracil (5-FU), and radiation therapy (RT) with selective organ preservation in patients with bladder cancer."3.71Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. ( Dunst, J; Grabenbauer, GG; Kühn, R; Papadopoulos, T; Rödel, C; Sauer, R; Schrott, KM; Zörcher, T, 2002)
"Local treatment with 5% of 5-Fluorouracil (5-Fu) in the form of globules was carried out on 37 patients with carcinoma in situ of the uterine cervix, established histologically, as the application was performed once daily for a period of 14-20 days."3.68[The conservative treatment of carcinoma in situ of the cervix uteri by the local application of 5-fluorouracil]. ( Chakalova, G; Karag'ozov, A; Marinova, L; Ralcheva, Ts, 1991)
"A patient with vaginal carcinoma in situ was treated with 5-fluorouracil in a less intensive regimen that previously recorded."3.66A new regimen for the treatment of vaginal carcinoma in situ using 5-fluorouracil. Case report. ( Hawthorne, JH; Stokes, IM; Sworn, MJ, 1980)
" Adenocarcinoma related to diethylstilbestrol exposure in utero is a recently recognized type of vaginal lesion, and melanoma and sarcoma occur rarely in the vagina."3.66Malignant tumors of the vagina. Classification and approach to treatment. ( Gerbie, MV, 1983)
"Topical 5-fluorouracil (5-FU) has been suggested as a simple and effective approach to the treatment of carcinoma in situ of the vulva."3.66Treatment of carcinoma in situ of the vulva with topical 5-fluorouracil. ( Lifshitz, S; Roberts, JA, 1980)
"Seven adult men with biopsy-confirmed erythroplasia of Queyrat (EQ) were cured of their disease with topically applied 5-fluorouracil (5-FU) under occlusion."3.65Erythroplasia of Queyrat: treatment with topical 5-fluorouracil. ( Carson, TE; Goette, DK, 1976)
"Overall accuracy of the residual cancer burden score determination was 0."2.80Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy. ( Albarracin, C; Downs-Kelly, E; Gould, R; Hatzis, C; Morkowski, J; Peintinger, F; Sinn, B; Symmans, WF, 2015)
"Anal cancer is an increasing issue in HIV-positive men who have sex with men (MSM)."2.78Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. ( de Vries, HJ; Dijkgraaf, MG; Prins, JM; Richel, O; van Noesel, CJ, 2013)
"Mitomycin C has been shown in studies to be highly effective but has short-term and long-term side-effects that may be intolerable."2.49Topical chemotherapy for ocular surface squamous neoplasia. ( Karp, CL; Nanji, AA; Sayyad, FE, 2013)
"A case of extramammary Paget's disease of the scrotum is presented."2.38Paget's disease of the scrotum: a case report and review of current literature. ( Boman, DA; Dudrey, EF; Moliver, CL; Morales, CA; Reedy, MB, 1991)
"Data on PeIN from the Swedish National Penile Cancer Register were analysed regarding treatment in relation to age, size of the PeIN lesion, localization of the PeIN lesion and complications using chi-squared tests and logistic regression."1.72Incidence of penile intraepithelial neoplasia and treatment strategies in Sweden 2000-2019. ( Bjartling, C; Forslund, O; Kristiansen, S; Svensson, Å; Torbrand, C, 2022)
" Fifty percent of patients reported Common Terminology Criteria for Adverse Events v5."1.62Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity. ( Aydin, AM; Chahoud, J; Cheryian, SK; Hajiran, A; Pow-Sang, JM; Spiess, PE; Zemp, L, 2021)
"To review outcomes of the treatment of carcinoma in situ (CIS) of the penis at a large supra-regional penile cancer network, where centralisation has permitted greater experience with treatment outcomes, and suggest treatment strategies."1.42The treatment of penile carcinoma in situ (CIS) within a UK supra-regional network. ( Jones, S; Lau, MW; Lucky, M; Murthy, KV; Parr, NJ; Rogers, B; Sangar, VK, 2015)
"The use of topical agents in the treatment of carcinoma in situ (CIS) of the penis has been well described in the literature."1.38Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. ( Alnajjar, HM; Bolgeri, M; Lam, W; Perry, MJ; Rees, RW; Watkin, NA, 2012)
" The most common side effect of this medication is localized irritant dermatitis."1.37Metallic taste as a side effect of topical fluorouracil use. ( Han, SY; Youker, S, 2011)
"Capecitabine was administered at a median dose of 1600 mg/m2/day (range, 1200-1800 mg/m2)."1.33A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer. ( Fontana, J; Forman, J; Frazier, A; Patel, B; Pontes, E; Vaishampayan, U, 2005)
"In the majority of patients with rectal cancer invading perirectal tissues or lymph nodes, lesions downstages by preoperative chemo radiotherapy."1.32[Preoperative radiation with chemotherapy for rectal cancer: its impact on downstaging of disease and the role of endorectal ultrasound]. ( Juska, P; Pavalkis, D; Pranys, D, 2004)
"To evaluate the efficacy of pulse dosing of topical 5-fluorouracil (5-FU) in the treatment of conjunctival and corneal intraepithelial neoplasia."1.315-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. ( Curry, CD; Engelbrecht, NE; Ford, JG; Walter, KA; Yeatts, RP, 2000)
"Patients diagnosed with Chronic Lymphocytic Leukemia (CLL) have an increased risk of developing second primary cancers."1.31Multiple neoplasms: a case report. ( Pigeaud-Klessens, ML; van der Valk, P, 2002)
"5-Fluorouracil showed to be an adequate treatment."1.29[Vaginal intraepithelial carcinoma. Diagnosis and management]. ( Chávez Brambilia, J; Deolarte Melgarejo, JM; González Sanchez, JL; Menéndez Velazquez, J, 1993)
"A retrospective study of 56 patients treated for carcinoma in situ of the vulva over a 24-year period has shown a relative increase in the occurrence of this neoplasm."1.27Wide local excision in the treatment of vulvar carcinoma in situ: a reappraisal. ( Gallup, DG; Wolcott, HD, 1984)
"The relation between the induction of delayed hypersensitivity reactions to 5-FU following treatment with topical 5-FU and the cure rate for cutaneous neoplasms showed a trend toward correlation."1.25Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers. ( Ichinose, H; Krementz, ET; Litwin, MS; Mansell, PW, 1975)

Research

Studies (98)

TimeframeStudies, this research(%)All Research%
pre-199040 (40.82)18.7374
1990's12 (12.24)18.2507
2000's21 (21.43)29.6817
2010's21 (21.43)24.3611
2020's4 (4.08)2.80

Authors

AuthorsStudies
Neale, H1
Michelon, M1
Jacob, S1
Pinkston, M1
Ukaegbu, R1
Zamor, W1
Morrison, E1
Deng, A1
Levin, NA1
Kristiansen, S1
Torbrand, C1
Svensson, Å1
Forslund, O1
Bjartling, C1
Hajiran, A1
Zemp, L1
Aydin, AM1
Cheryian, SK1
Pow-Sang, JM1
Chahoud, J1
Spiess, PE1
Stewart, JR1
Lang, ME1
Brewer, JD1
Tranoulis, A1
Georgiou, D1
Laios, A1
Theophilou, G1
Thangavelu, A1
Hutson, RC1
García de Oteyza, G1
Vázquez-Romo, KA1
Garcia-Vazquez, R1
Bermúdez-Cobos, D1
Ramos-Betancourt, N1
Richel, O1
de Vries, HJ1
van Noesel, CJ1
Dijkgraaf, MG1
Prins, JM1
Nanji, AA1
Sayyad, FE1
Karp, CL3
Bejarano, PA1
Boutros, M1
Berho, M1
Lucky, M1
Murthy, KV1
Rogers, B1
Jones, S1
Lau, MW1
Sangar, VK1
Parr, NJ1
Kenawy, N1
Garrick, A1
Heimann, H1
Coupland, SE1
Damato, BE1
Rashidi, A1
Amarillo, I1
Fisher, SI1
Peintinger, F1
Sinn, B1
Hatzis, C1
Albarracin, C1
Downs-Kelly, E1
Morkowski, J1
Gould, R1
Symmans, WF1
Jambusaria-Pahlajani, A1
Ortman, S1
Schmults, CD1
Liang, C1
Veloz-Martínez, MG1
Quintana-Romero, V1
Contreras-Morales, Mdel R1
Jiménez-Vieyra, CR1
Hsu, SH1
Gan, SD1
Nguyen, BT1
Konnikov, N1
Liang, CA1
Iovieno, A1
Lambiase, A1
Moretti, C1
Perrella, E1
Bonini, S1
Jinno, H1
Sakata, M1
Hayashida, T1
Takahashi, M1
Mukai, M1
Ikeda, T1
Kitagawa, Y1
Paczos, TA1
Ackers, S1
Odunsi, K1
Lele, S1
Mhawech-Fauceglia, P1
Terushkin, V1
Braga, JC1
Dusza, SW1
Scope, A1
Busam, K1
Marghoob, AA1
Gill, M1
Halpern, AC1
Ferreira, A1
Vieira, C1
Rodrigues, A1
Pereira, D1
Rodrigues, H1
Dávila, C1
Bento, S1
Shousha, MA1
Perez, VL1
Hoffmann, R1
Ventura, R1
Chang, V1
Dubovy, SR2
Wang, J1
Han, SY1
Youker, S1
Alnajjar, HM1
Lam, W1
Bolgeri, M1
Rees, RW1
Perry, MJ1
Watkin, NA1
Galor, A1
Oellers, P1
Kao, AA1
Abdelaziz, A1
Feuer, W1
Costello, E1
Greenhalf, W1
Neoptolemos, JP1
Schechter, BA2
Nagler, RS2
Snyder, ME1
Semiglazov, VF1
Maksimov, SIa1
Semiglazov, VV1
Kosnikov, AG1
Juska, P1
Pavalkis, D1
Pranys, D1
Murta, EF1
Neves Junior, MA1
Sempionato, LR1
Costa, MC1
Maluf, PJ1
Patel, B1
Forman, J1
Fontana, J1
Frazier, A1
Pontes, E1
Vaishampayan, U1
Downs, AM1
Geraghty, JM1
Jones, C1
Ondo, AL1
Mings, SM1
Pestak, RM1
Shanler, SD1
Tytherleigh, MG1
Birtle, AJ1
Cohen, CE1
Glynne-Jones, R1
Livingstone, J1
Gilbert, J1
Perrett, CM1
McGregor, JM1
Warwick, J1
Karran, P1
Leigh, IM1
Proby, CM1
Harwood, CA1
Weinberg, JM1
Soloway, MS1
Wolcott, HD1
Gallup, DG1
Seniukov, MV1
Goldobenko, GV1
Mardynskiĭ, IuS1
Lushnikov, EF1
Skoropad, IuD1
Gerbie, MV1
Petrilli, ES1
Townsend, DE2
Morrow, CP2
Nakao, CY1
Hofmann, W1
Langkopf, B1
Caglar, H3
Tamer, S1
Hreshchyshyn, MM3
Pride, GL1
Chuprevich, TW1
Foster, DC1
Woodruff, JD3
Sillman, FH2
Boyce, JG2
Macasaet, MA1
Nicastri, AD1
Hertzog, RW1
Daly, JW1
Ellis, GF1
Lifshitz, S1
Roberts, JA2
Stokes, IM1
Sworn, MJ1
Hawthorne, JH1
Hofmann, M1
Mahlke, M1
Casper, F1
Brockerhoff, P1
González Sanchez, JL1
Chávez Brambilia, J1
Menéndez Velazquez, J1
Deolarte Melgarejo, JM1
van Slooten, HJ1
Clahsen, PC1
van Dierendonck, JH1
Duval, C1
Pallud, C1
Mandard, AM1
Delobelle-Deroide, A1
van de Velde, CJ1
van de Vijver, MJ1
Kotoulas, IG2
Cardamakis, E2
Relakis, K2
Diamantis, A1
Papathanasiou, Z2
Korantzis, A2
Mantouvalos, C1
Yeatts, RP2
Ford, JG2
Stanton, CA1
Reed, JW1
Ginopoulos, P1
Metalinos, K1
Stathopoulos, E1
Michopoulos, J1
Mantouvalos, H1
Tzingounis, V1
Fowble, B1
Hanlon, AL1
Patchefsky, A1
Freedman, G1
Hoffman, JP1
Sigurdson, ER1
Goldstein, LJ1
Campagnutta, E1
Parin, A1
De Piero, G1
Giorda, G1
Gallo, A1
Scarabelli, C1
Engelbrecht, NE1
Curry, CD1
Walter, KA1
Pehoushek, J1
Smith, KJ1
Cardosi, RJ1
Bomalaski, JJ1
Hoffman, MS1
Burcombe, RJ1
Makris, A1
Pittam, M1
Lowe, J1
Emmott, J1
Wong, WL1
Yamamoto, N1
Ohmura, T1
Suzuki, H1
Shirasawa, H1
Rödel, C2
Grabenbauer, GG2
Kühn, R2
Dunst, J2
Papadopoulos, T2
Schrott, KM2
Sauer, R2
Zörcher, T1
Pigeaud-Klessens, ML1
van der Valk, P1
Habs, M1
Ang, J1
Schmähl, D1
Kaufman, RH1
Ballon, SC1
Lagasse, LD2
Krupp, PJ1
Bohm, JW1
Forney, JP1
DiSaia, PJ1
Goette, DK2
Carson, TE2
Hoskins, WJ1
Wurzel, JF1
Mansell, PW1
Litwin, MS3
Ichinose, H2
Krementz, ET2
Parmley, TH1
Julian, CG1
Cheson, BD2
Ungerleider, RS1
Grau, C1
Overgaard, J1
Reedy, MB1
Morales, CA1
Moliver, CL1
Dudrey, EF1
Boman, DA1
Chakalova, G1
Karag'ozov, A1
Marinova, L1
Ralcheva, Ts1
Abdennader, S1
Lessana-Leibowitch, M1
Pelisse, M1
Krebs, HB2
Sedlis, A1
Barten, G1
de Keizer, RJ1
de Wolff-Rouendaal, D1
van Delft, JL1
Bernstein, G1
Forgaard, DM1
Miller, JE1
Delgado, G1
Meyer, JS1
Lathrop, JC1
Ree, HJ1
McDuff, HC1
Weintraub, I1
Ryan, RF1
Reed, RR1
Kremetz, ET1
Dean, RE1
Taylor, ES1
Weisbrod, DM1
Martin, JW1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Study of Pomalidomide in Anal Cancer Precursors (SPACE): a Phase 2 Study of Immunomodulation in People With Persistent HPV-associated High Grade Squamous Intraepithelial Lesions[NCT03113942]Phase 226 participants (Actual)Interventional2017-06-14Active, not recruiting
Efficacy and Safety of Topical Trichloroacetic Acid vs. Electrocautery for the Treatment of Anal Intraepithelial Neoplasia in HIV-positive Patients (TECAIN) - a Randomized Controlled Trial[NCT02615860]560 participants (Actual)Interventional2015-11-30Completed
A Multicenter Observational and Feasibility Study of Excision of Superficially Invasive Squamous Cell Carcinoma (SISCCA) of the Anal Canal and Perianus in HIV-Infected Persons[NCT02437851]Phase 216 participants (Actual)Interventional2015-04-30Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

12 reviews available for fluorouracil and Carcinoma in Situ

ArticleYear
Efficacy of nonexcisional treatment modalities for superficially invasive and in situ squamous cell carcinoma: A systematic review and meta-analysis.
    Journal of the American Academy of Dermatology, 2022, Volume: 87, Issue:1

    Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Skin Neoplasms

2022
5-Flouorouracil Is an Attractive Medical Treatment in Women With Vaginal Intraepithelial Neoplasia: A Meta-Analysis.
    Journal of lower genital tract disease, 2018, Volume: 22, Issue:4

    Topics: Antineoplastic Agents; Carcinoma in Situ; Female; Fluorouracil; Humans; Observational Studies as Top

2018
Topical chemotherapy for ocular surface squamous neoplasia.
    Current opinion in ophthalmology, 2013, Volume: 24, Issue:4

    Topics: Administration, Topical; Antimetabolites, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms;

2013
Anal squamous intraepithelial neoplasia.
    Gastroenterology clinics of North America, 2013, Volume: 42, Issue:4

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; A

2013
New biomarkers and targets in pancreatic cancer and their application to treatment.
    Nature reviews. Gastroenterology & hepatology, 2012, Volume: 9, Issue:8

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma in Situ; Carcinoma, Pan

2012
Topical therapy for actinic keratoses: current and evolving therapies.
    Reviews on recent clinical trials, 2006, Volume: 1, Issue:1

    Topics: Administration, Cutaneous; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinom

2006
Diagnosis and management of vulvar and vaginal intraepithelial neoplasia.
    Obstetrics and gynecology clinics of North America, 2001, Volume: 28, Issue:4

    Topics: Administration, Topical; Antimetabolites, Antineoplastic; Biopsy; Carcinoma in Situ; Female; Fluorou

2001
Invasive bladder cancer: organ preservation by radiochemotherapy.
    Frontiers of radiation therapy and oncology, 2002, Volume: 36

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carbopla

2002
Intraepithelial carcinoma of the vulva.
    Obstetrics and gynecology annual, 1977, Volume: 6

    Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorouracil; Humans;

1977
Topical 5-fluorouracil in the treatment of carcinoma in situ of the vulva.
    Obstetrics and gynecology, 1976, Volume: 47, Issue:1

    Topics: Administration, Topical; Adult; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Fluorouracil; H

1976
Paget's disease of the scrotum: a case report and review of current literature.
    Texas medicine, 1991, Volume: 87, Issue:10

    Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorouracil; Genital Neopla

1991
A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil.
    Obstetrical & gynecological survey, 1985, Volume: 40, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Anal Canal; Anus Neoplasms; Carc

1985

Trials

10 trials available for fluorouracil and Carcinoma in Situ

ArticleYear
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
    The Lancet. Oncology, 2013, Volume: 14, Issue:4

    Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec

2013
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
    The Lancet. Oncology, 2013, Volume: 14, Issue:4

    Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec

2013
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
    The Lancet. Oncology, 2013, Volume: 14, Issue:4

    Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec

2013
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
    The Lancet. Oncology, 2013, Volume: 14, Issue:4

    Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec

2013
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
    The Lancet. Oncology, 2013, Volume: 14, Issue:4

    Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec

2013
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
    The Lancet. Oncology, 2013, Volume: 14, Issue:4

    Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec

2013
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
    The Lancet. Oncology, 2013, Volume: 14, Issue:4

    Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec

2013
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
    The Lancet. Oncology, 2013, Volume: 14, Issue:4

    Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec

2013
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
    The Lancet. Oncology, 2013, Volume: 14, Issue:4

    Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec

2013
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2015, Volume: 28, Issue:7

    Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Chemotherapy,

2015
A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma in

2010
[The modern organ- and function-sparing surgical treatment in oncology].
    Vestnik Rossiiskoi akademii meditsinskikh nauk, 2003, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carci

2003
Fluorouracil does not improve the outcome of imiquimoid treatment of vulval intraepethelial neoplasia.
    Acta dermato-venereologica, 2005, Volume: 85, Issue:4

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Drug Therapy,

2005
Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy.
    The British journal of dermatology, 2007, Volume: 156, Issue:2

    Topics: Administration, Topical; Aged; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Bowen's Disease

2007
Systemic therapy for superficial bladder cancer.
    Urology, 1984, Volume: 23, Issue:4 Suppl

    Topics: Animals; Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Clinical Trials as Topic; Cyclophospha

1984
Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.
    British journal of cancer, 1996, Volume: 74, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma in Situ; Carcino

1996
Treatment of penile intraepithelial neoplasia (PIN) with interferon alpha-2a, CO2 laser (vaporization) and 5-fluorouracil 5% (5-FU).
    European journal of gynaecological oncology, 1997, Volume: 18, Issue:5

    Topics: Administration, Topical; Adult; Antineoplastic Combined Chemotherapy Protocols; Carbon Dioxide; Carc

1997
Prophylactic topical 5-fluorouracil following treatment of human papillomavirus-associated lesions of the vulva and vagina.
    Obstetrics and gynecology, 1986, Volume: 68, Issue:6

    Topics: Administration, Intravaginal; Administration, Topical; Carcinoma in Situ; Combined Modality Therapy;

1986

Other Studies

76 other studies available for fluorouracil and Carcinoma in Situ

ArticleYear
Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis.
    Journal of the American Academy of Dermatology, 2022, Volume: 87, Issue:2

    Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorou

2022
Incidence of penile intraepithelial neoplasia and treatment strategies in Sweden 2000-2019.
    BJU international, 2022, Volume: 129, Issue:6

    Topics: Adult; Carcinoma in Situ; Fluorouracil; Humans; Imiquimod; Incidence; Male; Penile Neoplasms; Sweden

2022
Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity.
    Urologic oncology, 2021, Volume: 39, Issue:1

    Topics: Administration, Topical; Adult; Aged; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous

2021
Complete regression of a giant conjunctival intraepithelial neoplasia using 5-Fluorouracil.
    Journal francais d'ophtalmologie, 2019, Volume: 42, Issue:6

    Topics: Administration, Topical; Aged; Antimetabolites, Antineoplastic; Carcinoma in Situ; Conjunctival Neop

2019
The treatment of penile carcinoma in situ (CIS) within a UK supra-regional network.
    BJU international, 2015, Volume: 115, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma in Situ; Circumcision, Male; Combin

2015
Conjunctival squamous cell neoplasia: the Liverpool Ocular Oncology Centre experience.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2015, Volume: 253, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Brachytherapy; Carcinoma in Situ; C

2015
BRCA2-associated therapy-related acute myeloid leukemia.
    Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Duct

2015
Sequential Curettage, 5-Fluorouracil, and Photodynamic Therapy for Field Cancerization of the Scalp and Face in Solid Organ Transplant Recipients.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2016, Volume: 42 Suppl 1

    Topics: Antimetabolites, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Ther

2016
[Treatment results for different categories of vaginal intraepithelial neoplasia with electrocoagulation, 5-fluorouracil and combined treatment].
    Ginecologia y obstetricia de Mexico, 2015, Volume: 83, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma in Situ; Carcinoma, Squam

2015
Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2016, Volume: 42, Issue:9

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinom

2016
Therapeutic effect of topical 5-fluorouracil in conjunctival squamous carcinoma is associated with changes in matrix metalloproteinases and tissue inhibitor of metalloproteinases expression.
    Cornea, 2009, Volume: 28, Issue:7

    Topics: Administration, Topical; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Carcinoma in Situ

2009
Primary vaginal adenocarcinoma arising in vaginal adenosis after CO2 laser vaporization and 5-fluorouracil therapy.
    International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2010, Volume: 29, Issue:2

    Topics: Adenocarcinoma; Biopsy; Carcinoma in Situ; DNA, Viral; Female; Fluorouracil; Histocytochemistry; Hum

2010
Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:10

    Topics: Algorithms; Aminoquinolines; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryosurgery; Curet

2010
Bevacizumab in the treatment of metastatic breast cancer: three case reports.
    Current opinion in oncology, 2011, Volume: 23 Suppl

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot

2011
Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography.
    Ophthalmology, 2011, Volume: 118, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Biopsy; Carcinoma in Situ; Conjunctival Neoplasms;

2011
Metallic taste as a side effect of topical fluorouracil use.
    Journal of drugs in dermatology : JDD, 2011, Volume: 10, Issue:10

    Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous C

2011
Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents.
    European urology, 2012, Volume: 62, Issue:5

    Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Fluorour

2012
Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.
    Ophthalmology, 2012, Volume: 119, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctival Neoplasms;

2012
Successful treatment with 5-Fu.
    Ophthalmology, 2003, Volume: 110, Issue:4

    Topics: Administration, Topical; Aged; Antineoplastic Agents; Carcinoma in Situ; Conjunctival Neoplasms; Cor

2003
Successful treatment with 5-Fu.
    Ophthalmology, 2003, Volume: 110, Issue:6

    Topics: Administration, Topical; Aged; Antineoplastic Agents; Carcinoma in Situ; Conjunctival Neoplasms; Cor

2003
Conjunctival intraepithelial neoplasia.
    Ophthalmology, 2003, Volume: 110, Issue:7

    Topics: Administration, Topical; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma in

2003
[Preoperative radiation with chemotherapy for rectal cancer: its impact on downstaging of disease and the role of endorectal ultrasound].
    Medicina (Kaunas, Lithuania), 2004, Volume: 40, Issue:1

    Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma in Situ; Chemotherapy, Adjuvant;

2004
Vaginal intraepithelial neoplasia: clinical-therapeutic analysis of 33 cases.
    Archives of gynecology and obstetrics, 2005, Volume: 272, Issue:4

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma in Situ; Combined Modality Therapy; Female;

2005
A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer.
    International journal of radiation oncology, biology, physics, 2005, Aug-01, Volume: 62, Issue:5

    Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma in Situ; Carcinoma

2005
Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6

    Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Co

2006
Combined surgery and chemoradiation as a treatment for the Buschke-Löwenstein tumour.
    The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 2006, Volume: 4, Issue:6

    Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinom

2006
Wide local excision in the treatment of vulvar carcinoma in situ: a reappraisal.
    American journal of obstetrics and gynecology, 1984, Nov-15, Volume: 150, Issue:6

    Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Follow-Up Studies; Hu

1984
[Procedure and results of combined radiation and surgical treatment of laryngeal cancer patients].
    Meditsinskaia radiologiia, 1983, Volume: 28, Issue:9

    Topics: Adult; Aged; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality T

1983
Malignant tumors of the vagina. Classification and approach to treatment.
    Postgraduate medicine, 1983, Volume: 73, Issue:2

    Topics: Adenocarcinoma; Adolescent; Adult; Carcinoma in Situ; Carcinoma, Squamous Cell; Child; Diethylstilbe

1983
Vaginal intraepithelial neoplasia: Biologic aspects and treatment with topical 5-fluorouracil and the carbon dioxide laser.
    American journal of obstetrics and gynecology, 1980, Oct-01, Volume: 138, Issue:3

    Topics: Adult; Aged; Carbon Dioxide; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Fluorouracil; Huma

1980
[Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
    Zeitschrift fur Urologie und Nephrologie, 1982, Volume: 75, Issue:12

    Topics: Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Co

1982
Vulvar intraepithelial neoplasia.
    Obstetrics and gynecology, 1982, Volume: 60, Issue:3

    Topics: Adolescent; Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Humans; Immunosuppression Therapy;

1982
Topical 5-fluorouracil treatment of transformation zone intraepithelial neoplasia of cervix and vagina.
    Obstetrics and gynecology, 1982, Volume: 60, Issue:4

    Topics: Administration, Topical; Carcinoma in Situ; Female; Fluorouracil; Humans; Uterine Cervical Dysplasia

1982
The use of dinitrochlorobenzene in the treatment of vulvar carcinoma in situ.
    Gynecologic oncology, 1981, Volume: 11, Issue:3

    Topics: Administration, Topical; Adult; Carcinoma in Situ; Dinitrochlorobenzene; Female; Fluorouracil; Human

1981
5-fluorouracil/chemosurgery for intraepithelial neoplasia of the lower genital tract.
    Obstetrics and gynecology, 1981, Volume: 58, Issue:3

    Topics: Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Genital Neoplasms, Female; Humans; Methods; Mi

1981
Topical 5-fluorouracil treatment of vaginal intraepithelial neoplasia.
    Obstetrics and gynecology, 1981, Volume: 58, Issue:5

    Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Drug Evaluation; Female; Fluorouracil; Huma

1981
Carcinoma in situ of the vagina.
    Clinical obstetrics and gynecology, 1981, Volume: 24, Issue:2

    Topics: Carcinoma in Situ; Female; Fluorouracil; Humans; Vagina; Vaginal Neoplasms

1981
Treatment of vaginal dysplasia and carcinoma in situ with topical 5-fluorouracil.
    Obstetrics and gynecology, 1980, Volume: 55, Issue:3

    Topics: Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Humans; Middle Aged; Neoplasms, Multiple Prima

1980
Treatment of carcinoma in situ of the vulva with topical 5-fluorouracil.
    Obstetrics and gynecology, 1980, Volume: 56, Issue:2

    Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Humans; Middle Aged;

1980
A new regimen for the treatment of vaginal carcinoma in situ using 5-fluorouracil. Case report.
    British journal of obstetrics and gynaecology, 1980, Volume: 87, Issue:10

    Topics: Administration, Topical; Carcinoma in Situ; Female; Fluorouracil; Humans; Middle Aged; Vagina; Vagin

1980
[Persistent granulocytosis and hyperuricemia after a single G-CSF injection (Filgrastim) in treatment of chemotherapy-induced myelosuppression in metastatic breast carcinoma].
    Zentralblatt fur Gynakologie, 1995, Volume: 117, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma in Si

1995
[Vaginal intraepithelial carcinoma. Diagnosis and management].
    Ginecologia y obstetricia de Mexico, 1993, Volume: 61

    Topics: Adult; Carcinoma in Situ; Colposcopy; Combined Modality Therapy; Cryosurgery; Female; Fluorouracil;

1993
Peoscopic diagnosis of flat condyloma and penile intraepithelial neoplasia. IV. Urethral reservoir.
    Gynecologic and obstetric investigation, 1996, Volume: 41, Issue:1

    Topics: Adolescent; Adult; Carcinoma in Situ; Condylomata Acuminata; Endothelium; Female; Fluorouracil; Huma

1996
Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea.
    Ophthalmology, 1995, Volume: 102, Issue:9

    Topics: Administration, Topical; Adult; Aged; Antimetabolites, Antineoplastic; Biopsy; Carcinoma in Situ; Ch

1995
The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    International journal of radiation oncology, biology, physics, 1998, Aug-01, Volume: 42, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neopl

1998
Treatment of vaginal intraepithelial neoplasia (VAIN) with the carbon dioxide laser.
    Clinical and experimental obstetrics & gynecology, 1999, Volume: 26, Issue:2

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma in Situ; Combined Modality Therapy; Evaluati

1999
5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea.
    Ophthalmology, 2000, Volume: 107, Issue:12

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma in Situ

2000
Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man.
    Archives of dermatology, 2001, Volume: 137, Issue:1

    Topics: Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma in Situ;

2001
Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography.
    European journal of cancer (Oxford, England : 1990), 2002, Volume: 38, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Chemothe

2002
Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C.
    Ophthalmology, 2002, Volume: 109, Issue:2

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma in Situ; Conjunctival Neopla

2002
Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil.
    International journal of radiation oncology, biology, physics, 2002, Apr-01, Volume: 52, Issue:5

    Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Cisplati

2002
Multiple neoplasms: a case report.
    Orbit (Amsterdam, Netherlands), 2002, Volume: 21, Issue:2

    Topics: Aged; Antimetabolites, Antineoplastic; Blepharoplasty; Carcinoma in Situ; Carcinoma, Squamous Cell;

2002
Chemotherapy studies in autochthonous rat tumors. Forestomach and bladder cancer.
    Zeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology, 1977, Jun-27, Volume: 89, Issue:2

    Topics: Animals; Antineoplastic Agents; Bleomycin; Carcinoma in Situ; Doxorubicin; Drug Combinations; Female

1977
Topical 5-fluorouracil in the treatment of intraepithelial neoplasia of the vagina.
    Obstetrics and gynecology, 1979, Volume: 54, Issue:2

    Topics: Administration, Topical; Carcinoma in Situ; Female; Fluorouracil; Humans; Neoplasm Recurrence, Local

1979
5-fluorouracil topical treatment of in situ vulvar cancer. A preliminary report.
    Obstetrics and gynecology, 1978, Volume: 51, Issue:6

    Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Humans; Middle Aged;

1978
Management of carcinoma in situ of the vulva.
    American journal of obstetrics and gynecology, 1977, Apr-15, Volume: 127, Issue:8

    Topics: Adult; Aged; Carcinoma in Situ; Colposcopy; Female; Fluorouracil; Humans; Middle Aged; Vulva; Vulvar

1977
Erythroplasia of Queyrat: treatment with topical 5-fluorouracil.
    Cancer, 1976, Volume: 38, Issue:4

    Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Erythroplasia; Fl

1976
Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers.
    Cancer research, 1975, Volume: 35, Issue:5

    Topics: Administration, Topical; Biopsy; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Basosquamous;

1975
Topical 5-fluorouracil in the treatment of vaginal carcinoma-in-situ.
    Gynecologic oncology, 1975, Volume: 3, Issue:2

    Topics: Administration, Topical; Adult; Carcinoma in Situ; Female; Fluorouracil; Humans; Middle Aged; Vagina

1975
Clinical trials referral resource. High priority trials--III. Breast cancer.
    Oncology (Williston Park, N.Y.), 1992, Volume: 6, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carci

1992
Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:4

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; C

1992
[The conservative treatment of carcinoma in situ of the cervix uteri by the local application of 5-fluorouracil].
    Akusherstvo i ginekologiia, 1991, Volume: 30, Issue:2

    Topics: Administration, Topical; Adult; Biopsy; Carcinoma in Situ; Cervix Uteri; Colposcopy; Female; Fluorou

1991
Clinical trials referral resource. Adjuvant therapy of breast cancer.
    Oncology (Williston Park, N.Y.), 1989, Volume: 3, Issue:6

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin;

1989
An atypical case of penile carcinoma in situ associated with human papillomavirus DNA type 18.
    Journal of the American Academy of Dermatology, 1989, Volume: 20, Issue:5 Pt 2

    Topics: Adult; Blotting, Southern; Carcinoma in Situ; DNA, Viral; Fluorouracil; Humans; Male; Papillomavirid

1989
Treatment of vaginal intraepithelial neoplasia with laser and topical 5-fluorouracil.
    Obstetrics and gynecology, 1989, Volume: 73, Issue:4

    Topics: Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Humans; Laser Therapy; Middle Aged; Vaginal Ne

1989
[Local treatment of cervical intraepithelial neoplasia with a 5 percent fluorouracil ointment].
    Zentralblatt fur Gynakologie, 1987, Volume: 109, Issue:24

    Topics: Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cervix Uteri; Condylomata Acuminata; Female; Fl

1987
Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid.
    Documenta ophthalmologica. Advances in ophthalmology, 1986, Dec-30, Volume: 64, Issue:1

    Topics: Aged; Carcinoma in Situ; Conjunctival Diseases; Corneal Diseases; Drug Administration Schedule; Eyel

1986
Carcinoma in situ of the glans penis and distal urethra.
    The Journal of dermatologic surgery and oncology, 1986, Volume: 12, Issue:5

    Topics: Adult; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorouracil; Humans;

1986
Partial and total skinning vulvectomy in treatment of carcinoma in situ of the vulva.
    Obstetrics and gynecology, 1986, Volume: 68, Issue:4

    Topics: Adolescent; Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recu

1986
Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma.
    NCI monographs : a publication of the National Cancer Institute, 1986, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma in Situ; Cell Cy

1986
Intraepithelial neoplasia of the neovagina.
    Obstetrics and gynecology, 1985, Volume: 65, Issue:3 Suppl

    Topics: Adult; Carcinoma in Situ; Epithelium; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged;

1985
Topical chemotherapy of basal and squamous skin cancers with 5-fluorouracil cream.
    Panminerva medica, 1974, Volume: 16, Issue:3

    Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Basosquamous; Carcinom

1974
Reversibility of vulvar atypia by DNCB-induced delayed hypersensitivity.
    Obstetrics and gynecology, 1973, Volume: 41, Issue:2

    Topics: Adult; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Chlorine; Female; Fluorouracil; Humans;

1973
Proceedings: Use of 5 fluorouracil in the topical therapy of skin cancer: a review of 157 patients.
    Proceedings. National Cancer Conference, 1972, Volume: 7

    Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Basosquam

1972
The treatment of premalignant and malignant lesions of the vulva.
    American journal of obstetrics and gynecology, 1974, May-01, Volume: 119, Issue:1

    Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Fluoroura

1974
Erythroplasia of Queyrat.
    Archives of dermatology, 1974, Volume: 110, Issue:2

    Topics: Administration, Topical; Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Ma

1974